About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Long Read Sequencing Size, Share, Trends & Forecast 2030
Long Read Sequencing Market

Long Read Sequencing Market Size, Share & Trends Analysis Report By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing), By Product and Services (Consumables, Instruments, Services), By Application (Identification and Fine Mapping of Structural Variation, Cancer, Viral and Microbial Sequencing, Reproductive Genomics, Tandem Repeat Sequencing, Resolving allele phasing), By Work Flow (Sequencing, Pre-Sequencing, Data Analysis), By End-User (Clinical Research, Academic Research, Pharma and Biotech Entities, Hospitals and Clinics) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI818DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Long Read Sequencing Market Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Single-Molecule Real-Time Sequencing (SMRT)
        1. By Value
      3. Nanopore Sequencing
        1. By Value
    3. By Product and Services
      1. Introduction
        1. Product and Services By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Identification and Fine Mapping of Structural Variation
        1. By Value
      3. Cancer
        1. By Value
      4. Viral and Microbial Sequencing
        1. By Value
      5. Reproductive Genomics
        1. By Value
      6. Tandem Repeat Sequencing
        1. By Value
      7. Resolving allele phasing
        1. By Value
    5. By Work Flow
      1. Introduction
        1. Work Flow By Value
      2. Sequencing
        1. By Value
      3. Pre-Sequencing
        1. By Value
      4. Data Analysis
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Research
        1. By Value
      3. Academic Research
        1. By Value
      4. Pharma and Biotech Entities
        1. By Value
      5. Hospitals and Clinics
        1. By Value
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Single-Molecule Real-Time Sequencing (SMRT)
        1. By Value
      3. Nanopore Sequencing
        1. By Value
    3. By Product and Services
      1. Introduction
        1. Product and Services By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Identification and Fine Mapping of Structural Variation
        1. By Value
      3. Cancer
        1. By Value
      4. Viral and Microbial Sequencing
        1. By Value
      5. Reproductive Genomics
        1. By Value
      6. Tandem Repeat Sequencing
        1. By Value
      7. Resolving allele phasing
        1. By Value
    5. By Work Flow
      1. Introduction
        1. Work Flow By Value
      2. Sequencing
        1. By Value
      3. Pre-Sequencing
        1. By Value
      4. Data Analysis
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Research
        1. By Value
      3. Academic Research
        1. By Value
      4. Pharma and Biotech Entities
        1. By Value
      5. Hospitals and Clinics
        1. By Value
    7. U.S.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Single-Molecule Real-Time Sequencing (SMRT)
          1. By Value
        3. Nanopore Sequencing
          1. By Value
      2. By Product and Services
        1. Introduction
          1. Product and Services By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Identification and Fine Mapping of Structural Variation
          1. By Value
        3. Cancer
          1. By Value
        4. Viral and Microbial Sequencing
          1. By Value
        5. Reproductive Genomics
          1. By Value
        6. Tandem Repeat Sequencing
          1. By Value
        7. Resolving allele phasing
          1. By Value
      4. By Work Flow
        1. Introduction
          1. Work Flow By Value
        2. Sequencing
          1. By Value
        3. Pre-Sequencing
          1. By Value
        4. Data Analysis
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Research
          1. By Value
        3. Academic Research
          1. By Value
        4. Pharma and Biotech Entities
          1. By Value
        5. Hospitals and Clinics
          1. By Value
    8. Canada
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Single-Molecule Real-Time Sequencing (SMRT)
        1. By Value
      3. Nanopore Sequencing
        1. By Value
    3. By Product and Services
      1. Introduction
        1. Product and Services By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Identification and Fine Mapping of Structural Variation
        1. By Value
      3. Cancer
        1. By Value
      4. Viral and Microbial Sequencing
        1. By Value
      5. Reproductive Genomics
        1. By Value
      6. Tandem Repeat Sequencing
        1. By Value
      7. Resolving allele phasing
        1. By Value
    5. By Work Flow
      1. Introduction
        1. Work Flow By Value
      2. Sequencing
        1. By Value
      3. Pre-Sequencing
        1. By Value
      4. Data Analysis
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Research
        1. By Value
      3. Academic Research
        1. By Value
      4. Pharma and Biotech Entities
        1. By Value
      5. Hospitals and Clinics
        1. By Value
    7. U.K.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Single-Molecule Real-Time Sequencing (SMRT)
          1. By Value
        3. Nanopore Sequencing
          1. By Value
      2. By Product and Services
        1. Introduction
          1. Product and Services By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Identification and Fine Mapping of Structural Variation
          1. By Value
        3. Cancer
          1. By Value
        4. Viral and Microbial Sequencing
          1. By Value
        5. Reproductive Genomics
          1. By Value
        6. Tandem Repeat Sequencing
          1. By Value
        7. Resolving allele phasing
          1. By Value
      4. By Work Flow
        1. Introduction
          1. Work Flow By Value
        2. Sequencing
          1. By Value
        3. Pre-Sequencing
          1. By Value
        4. Data Analysis
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Research
          1. By Value
        3. Academic Research
          1. By Value
        4. Pharma and Biotech Entities
          1. By Value
        5. Hospitals and Clinics
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Single-Molecule Real-Time Sequencing (SMRT)
        1. By Value
      3. Nanopore Sequencing
        1. By Value
    3. By Product and Services
      1. Introduction
        1. Product and Services By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Identification and Fine Mapping of Structural Variation
        1. By Value
      3. Cancer
        1. By Value
      4. Viral and Microbial Sequencing
        1. By Value
      5. Reproductive Genomics
        1. By Value
      6. Tandem Repeat Sequencing
        1. By Value
      7. Resolving allele phasing
        1. By Value
    5. By Work Flow
      1. Introduction
        1. Work Flow By Value
      2. Sequencing
        1. By Value
      3. Pre-Sequencing
        1. By Value
      4. Data Analysis
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Research
        1. By Value
      3. Academic Research
        1. By Value
      4. Pharma and Biotech Entities
        1. By Value
      5. Hospitals and Clinics
        1. By Value
    7. China
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Single-Molecule Real-Time Sequencing (SMRT)
          1. By Value
        3. Nanopore Sequencing
          1. By Value
      2. By Product and Services
        1. Introduction
          1. Product and Services By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Identification and Fine Mapping of Structural Variation
          1. By Value
        3. Cancer
          1. By Value
        4. Viral and Microbial Sequencing
          1. By Value
        5. Reproductive Genomics
          1. By Value
        6. Tandem Repeat Sequencing
          1. By Value
        7. Resolving allele phasing
          1. By Value
      4. By Work Flow
        1. Introduction
          1. Work Flow By Value
        2. Sequencing
          1. By Value
        3. Pre-Sequencing
          1. By Value
        4. Data Analysis
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Research
          1. By Value
        3. Academic Research
          1. By Value
        4. Pharma and Biotech Entities
          1. By Value
        5. Hospitals and Clinics
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Single-Molecule Real-Time Sequencing (SMRT)
        1. By Value
      3. Nanopore Sequencing
        1. By Value
    3. By Product and Services
      1. Introduction
        1. Product and Services By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Identification and Fine Mapping of Structural Variation
        1. By Value
      3. Cancer
        1. By Value
      4. Viral and Microbial Sequencing
        1. By Value
      5. Reproductive Genomics
        1. By Value
      6. Tandem Repeat Sequencing
        1. By Value
      7. Resolving allele phasing
        1. By Value
    5. By Work Flow
      1. Introduction
        1. Work Flow By Value
      2. Sequencing
        1. By Value
      3. Pre-Sequencing
        1. By Value
      4. Data Analysis
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Research
        1. By Value
      3. Academic Research
        1. By Value
      4. Pharma and Biotech Entities
        1. By Value
      5. Hospitals and Clinics
        1. By Value
    7. UAE
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Single-Molecule Real-Time Sequencing (SMRT)
          1. By Value
        3. Nanopore Sequencing
          1. By Value
      2. By Product and Services
        1. Introduction
          1. Product and Services By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Identification and Fine Mapping of Structural Variation
          1. By Value
        3. Cancer
          1. By Value
        4. Viral and Microbial Sequencing
          1. By Value
        5. Reproductive Genomics
          1. By Value
        6. Tandem Repeat Sequencing
          1. By Value
        7. Resolving allele phasing
          1. By Value
      4. By Work Flow
        1. Introduction
          1. Work Flow By Value
        2. Sequencing
          1. By Value
        3. Pre-Sequencing
          1. By Value
        4. Data Analysis
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Research
          1. By Value
        3. Academic Research
          1. By Value
        4. Pharma and Biotech Entities
          1. By Value
        5. Hospitals and Clinics
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Single-Molecule Real-Time Sequencing (SMRT)
        1. By Value
      3. Nanopore Sequencing
        1. By Value
    3. By Product and Services
      1. Introduction
        1. Product and Services By Value
      2. Consumables
        1. By Value
      3. Instruments
        1. By Value
      4. Services
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Identification and Fine Mapping of Structural Variation
        1. By Value
      3. Cancer
        1. By Value
      4. Viral and Microbial Sequencing
        1. By Value
      5. Reproductive Genomics
        1. By Value
      6. Tandem Repeat Sequencing
        1. By Value
      7. Resolving allele phasing
        1. By Value
    5. By Work Flow
      1. Introduction
        1. Work Flow By Value
      2. Sequencing
        1. By Value
      3. Pre-Sequencing
        1. By Value
      4. Data Analysis
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Clinical Research
        1. By Value
      3. Academic Research
        1. By Value
      4. Pharma and Biotech Entities
        1. By Value
      5. Hospitals and Clinics
        1. By Value
    7. Brazil
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Single-Molecule Real-Time Sequencing (SMRT)
          1. By Value
        3. Nanopore Sequencing
          1. By Value
      2. By Product and Services
        1. Introduction
          1. Product and Services By Value
        2. Consumables
          1. By Value
        3. Instruments
          1. By Value
        4. Services
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Identification and Fine Mapping of Structural Variation
          1. By Value
        3. Cancer
          1. By Value
        4. Viral and Microbial Sequencing
          1. By Value
        5. Reproductive Genomics
          1. By Value
        6. Tandem Repeat Sequencing
          1. By Value
        7. Resolving allele phasing
          1. By Value
      4. By Work Flow
        1. Introduction
          1. Work Flow By Value
        2. Sequencing
          1. By Value
        3. Pre-Sequencing
          1. By Value
        4. Data Analysis
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Clinical Research
          1. By Value
        3. Academic Research
          1. By Value
        4. Pharma and Biotech Entities
          1. By Value
        5. Hospitals and Clinics
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Long Read Sequencing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Illumina, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. MicrobesNG
    3. Stratos Genomics (Hoffmann-La Roche Ltd.)
    4. Pacific Biosciences of California, Inc.
    5. Oxford Nanopore
    6. Quantapore, Inc.
    7. FG Technologies
    8. BaseClear B.V
    9. Institute of Integrative Cell Biology
    10. The Garvan Institute of Medical Research
    11. The Bordeaux Transcriptome Genome Platform
    12. Takara Bio Inc. (Takara Holdings Inc.)
    13. Genexa AG
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Genome Sequencing Market Size The global genome sequencing market size was valued at USD 41.92 billion in 2023 and is projected to reach USD 101.23 billion by 2032, growing at a CAGR of 11.7% during the forecast period (2024–2032). Genome sequencin
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.